Most newly discharged patients who recently recovered from COVID-19 produce virus-specific antibodies and T cells, a new study suggests, but the responses of different patients are not all the same. While the 14 patients examined in the study showed wide-ranging immune responses, results from the 6 of them that were assessed at two weeks after discharge suggest that antibodies were maintained for at least that long.
